Russell Investments Group, Ltd. Kymera Therapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

$69.8 Billion
Q4 2024

A detailed history of Russell Investments Group, Ltd. transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 58,923 shares of KYMR stock, worth $2.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

58,923

Previous 59,783 1.44%

Holding current value

$2.03 Million

Previous $2.83 Million 16.22%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$39.06 - $51.84 $33,591 - $44,582	-860 Reduced 1.44%	58,923 $2.37 Million
Q3 2024 Nov 13, 2024	BUY	$30.16 - $52.4 $191,516 - $332,740	6,350 Added 11.88%	59,783 $2.83 Million
Q2 2024 Aug 08, 2024	BUY	$29.85 - $39.42 $50,028 - $66,067	1,676 Added 3.24%	53,433 $1.59 Million
Q1 2024 May 08, 2024	BUY	$22.9 - $43.57 $60,593 - $115,286	2,646 Added 5.39%	51,757 $2.08 Million
Q4 2023 Feb 05, 2024	BUY	$10.97 - $26.84 $197,449 - $483,093	17,999 Added 57.85%	49,111 $1.25 Million
Q3 2023 Nov 13, 2023	BUY	$13.9 - $23.88 $179,935 - $309,126	12,945 Added 71.26%	31,112 $432,000
Q2 2023 Aug 10, 2023	SELL	$22.4 - $34.92 $218,915 - $341,273	-9,773 Reduced 34.98%	18,167 $417,000
Q1 2023 May 09, 2023	SELL	$24.84 - $38.75 $24,318 - $37,936	-979 Reduced 3.39%	27,940 $827,000
Q4 2022 Feb 08, 2023	BUY	$19.57 - $30.92 $116,324 - $183,788	5,944 Added 25.87%	28,919 $721,000
Q3 2022 Nov 04, 2022	BUY	$20.91 - $34.27 $55,411 - $90,815	2,650 Added 13.04%	22,975 $498,000
Q2 2022 Jul 29, 2022	BUY	$14.13 - $42.55 $287,192 - $864,828	20,325 New	20,325 $398,000
Q4 2021 Jan 21, 2022	SELL	$49.91 - $65.56 $184,617 - $242,506	-3,699 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$47.8 - $66.66 $176,812 - $246,575	3,699 New	3,699 $217,000
Q2 2021 Aug 04, 2021	SELL	$31.08 - $51.95 $767,178 - $1.28 Million	-24,684 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$35.64 - $85.46 $702,286 - $1.68 Million	19,705 Added 395.76%	24,684 $951,000
Q4 2020 Feb 08, 2021	BUY	$28.07 - $87.83 $139,760 - $437,305	4,979 New	4,979 $357,000

Others Institutions Holding KYMR

# of Institutions

186

Shares Held

65.6M

Call Options Held

49.6K

Put Options Held

17K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $1.89B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Kymera Therapeutics, Inc. Transaction History